Close Menu

NEW YORK – The US Food and Drug Administration on Friday granted Emergency Use Authorization for a molecular diagnostic test for SARS-CoV-2 developed by Primerdesign, the UK-based molecular diagnostics division of clinical diagnostics company Novacyt.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.